Article info
PDFClinical science
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease
- Correspondence to Professor Manabu Mochizuki, Department of Ophthalmology & Visual Science, Tokyo Medical and Dental University Graduate School of Medicine, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan; m.manabu.oph{at}tmd.ac.jp
Citation
Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease
Publication history
- Accepted May 30, 2009
- First published August 18, 2009.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2009, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.